About this Journal Submit a Manuscript Table of Contents
Journal of Allergy
Volume 2012 (2012), Article ID 108149, 7 pages
http://dx.doi.org/10.1155/2012/108149
Review Article

Neuronal Modulation of Airway and Vascular Tone and Their Influence on Nonspecific Airways Responsiveness in Asthma

1Department of Allergy and Clinical Immunology, Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224, USA
2School of Biomedical Sciences, University of Queensland, Brisbane, QLD 4072, Australia

Received 1 August 2012; Accepted 28 September 2012

Academic Editor: Ynuk Bossé

Copyright © 2012 Brendan J. Canning et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Heart, Lung and Blood Institute (NHLBI), “Guidelines for the diagnosis and management of asthma.,” Expert Panel Report 3 07-4051, National Institutes of Health (NIH) Publication, 2007.
  2. British Thoracic Society Scottish Intercollegiate Guidelines Network, “British Guideline on the Management of Asthma,” Thorax, vol. 63, supplement 4, pp. iv1–iv121, 2008.
  3. S. P. Peters, S. J. Kunselman, N. Icitovic et al., “Tiotropium bromide step-up therapy for adults with uncontrolled asthma,” The New England Journal of Medicine, vol. 363, no. 18, pp. 1715–1726, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. L. J. Smith, “Anticholinergics for patients with asthma?” The New England Journal of Medicine, vol. 363, no. 18, pp. 1764–1765, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Bousquet, P. K. Jeffery, W. W. Busse, M. Johnson, and A. M. Vignola, “Asthma: from bronchoconstriction to airways inflammation and remodeling,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 5, pp. 1720–1745, 2000. View at Scopus
  6. E. Crimi, A. Spanevello, M. Neri, P. W. Ind, G. A. Rossi, and V. Brusasco, “Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 1, pp. 4–9, 1998. View at Scopus
  7. Q. Hamid and M. Tulic, “Immunobiology of asthma,” Annual Review of Physiology, vol. 71, pp. 489–507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. I. Tillie-Leblond, D. Montani, B. Crestani et al., “Relation between inflammation and symptoms in asthma,” Allergy, vol. 64, no. 3, pp. 354–367, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Baroffio, G. Barisione, E. Crimi, and V. Brusasco, “Noninflammatory mechanisms of airway hyper-responsiveness in bronchial asthma: an overview,” Therapeutic Advances in Respiratory Disease, vol. 3, no. 4, pp. 163–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. G. Gibson, J. Dolovich, J. Denburg, E. H. Ramsdale, and F. E. Hargreave, “Chronic cough: eosinophilic bronchitis without asthma,” The Lancet, vol. 1, no. 8651, pp. 1346–1348, 1989. View at Scopus
  11. E. M. Karjalainen, A. Laitinen, M. Sue-Chu, A. Altraja, L. Bjermer, and L. A. Laitinen, “Evidence of airway inflammation and remodeling in ski athletes with and without bronchial hyperresponsiveness to methacholine,” American Journal of Respiratory and Critical Care Medicine, vol. 161, no. 6, pp. 2086–2091, 2000. View at Scopus
  12. J. A. Kermode, N. J. Brown, K. M. Hardaker et al., “The effect of airway remodelling on airway hyper-responsiveness in asthma,” Respiratory Medicine, vol. 105, no. 12, pp. 1798–1804, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Niimi, H. Matsumoto, M. Takemura, T. Ueda, K. Chin, and M. Mishima, “Relationship of airway wall thickness to airway sensitivity and airway reactivity in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 8, pp. 983–988, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. A. D. Klion, M. A. Law, W. Riemenscheider, et al., “Familial eosinophilia: a benign disorder?” Blood, vol. 103, no. 11, pp. 4050–4055, 2004.
  15. J. Chakir, M. Laviolette, H. Turcotte, M. Boutet, and L. P. Boulet, “Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure,” Journal of Allergy and Clinical Immunology, vol. 106, no. 5, pp. 904–910, 2000. View at Publisher · View at Google Scholar · View at Scopus
  16. J. R. Shaver, J. J. O'Connor, M. Pollice et al., “Pulmonary inflammation after segmental ragweed challenge in allergic asthmatic and nonasthmatic subjects,” American Journal of Respiratory and Critical Care Medicine, vol. 152, no. 4, pp. 1189–1197, 1995. View at Scopus
  17. K. W. McGrath, N. Icitovic, H. A. Boushey, et al., “A large subgroup of mild-to-moderate asthma is persistently noneosinophilic,” American Journal of Respiratory and Critical Care Medicine, vol. 185, no. 6, pp. 612–619, 2012.
  18. S. A. Bryan, B. J. O'Connor, S. Matti et al., “Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response,” The Lancet, vol. 356, pp. 2149–2153, 2000. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Flood-Page, C. Swenson, I. Faiferman et al., “A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 11, pp. 1062–1071, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. J. Leckie, A. Ten Brinke, J. Khan et al., “Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response,” The Lancet, vol. 356, pp. 2144–2148, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Nair, M. M. M. Pizzichini, M. Kjarsgaard et al., “Mepolizumab for prednisone-dependent asthma with sputum eosinophilia,” The New England Journal of Medicine, vol. 360, no. 10, pp. 985–993, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. CAMP Study Investigators, “Long-term effects of budesonide or nedocromil in children with asthma. The Childhood Asthma Management Program Research Group,” The New England Journal of Medicine, vol. 343, no. 15, pp. 1054–1063, 2000.
  23. C. L. Armour, J. L. Black, N. Berend, and A. J. Woolcock, “The relationship between bronchial hyperresponsiveness to methacholine and airway smooth muscle structure and reactivity,” Respiration Physiology, vol. 58, no. 2, pp. 223–233, 1984. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Cerrina, C. Labat, I. Haye-Legrande, B. Raffestin, J. Benveniste, and C. Brink, “Human isolated bronchial muscle preparations from asthmatic patients: effects of indomethacin and contractile agonists,” Prostaglandins, vol. 37, no. 4, pp. 457–469, 1989. View at Scopus
  25. J. A. Roberts, D. Raeburn, I. W. Rodger, and N. C. Thomson, “Comparison of in vivo airway responsiveness and in vitro smooth muscle sensitivity to methacholine in man,” Thorax, vol. 39, no. 11, pp. 837–843, 1984. View at Scopus
  26. C. J. Van Koppen, J. F. Rodrigues de Miranda, A. J. Beld, C. A. M. Van Ginneken, J. W. J. Lammers, and C. L. A. Van Herwaarden, “Muscarinic receptor sensitivity in airway smooth muscle of patients with obstructive airway disease,” Archives Internationales de Pharmacodynamie et de Therapie, vol. 295, pp. 238–244, 1988. View at Scopus
  27. S. Bianco, M. G. Pieroni, R. M. Refini, L. Rottoli, and P. Sestini, “Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions,” The New England Journal of Medicine, vol. 321, no. 16, pp. 1069–1073, 1989. View at Scopus
  28. R. W. Mitchell, E. Ruhlmann, H. Magnussen, A. R. Leff, and K. F. Rabe, “Passive sensitization of human bronchi augments smooth muscle shortening velocity and capacity,” American Journal of Physiology, vol. 267, no. 2, pp. L218–L222, 1994. View at Scopus
  29. R. G. Goldie, D. Spina, P. J. Henry, et al., “In vitro responsiveness of human asthmatic bronchus to carbachol, histamine, β-adrenoceptor agonists and theophylline,” British Journal of Clinical Pharmacology, vol. 22, no. 6, pp. 669–676, 1986. View at Scopus
  30. S. D. Whicker, C. L. Armour, and J. L. Black, “Responsiveness of bronchial smooth muscle from asthmatic patients to relaxant and contractile agonists,” Pulmonary Pharmacology, vol. 1, no. 1, pp. 25–31, 1988. View at Scopus
  31. Y. Jammes and N. Mei, “Assessment of the pulmonary origin of bronchoconstrictor vagal tone,” Journal of Physiology, vol. 291, pp. 305–316, 1979. View at Scopus
  32. B. S. Kesler and B. J. Canning, “Regulation of baseline cholinergic tone in guinea-pig airway smooth muscle,” Journal of Physiology, vol. 518, no. 3, pp. 843–855, 1999. View at Publisher · View at Google Scholar · View at Scopus
  33. B. S. Kesler, S. B. Mazzone, and B. J. Canning, “Nitric oxide-dependent modulation of smooth-muscle tone by airway parasympathetic nerves,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 4, pp. 481–488, 2002. View at Scopus
  34. S. B. Mazzone and B. J. Canning, “Evidence for differential reflex regulation of cholinergic and noncholinergic parasympathetic nerves innervating the airways,” American Journal of Respiratory and Critical Care Medicine, vol. 165, no. 8, pp. 1076–1083, 2002. View at Scopus
  35. B. J. Canning, “Reflex regulation of airway smooth muscle tone,” Journal of Applied Physiology, vol. 101, no. 3, pp. 971–985, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. B. J. Canning and A. Fischer, “Localization of cholinergic nerves in lower airways of guinea pigs using antisera to choline acetyltransferase,” American Journal of Physiology, vol. 272, no. 4, pp. L731–L738, 1997. View at Scopus
  37. B. J. Canning and B. J. Undem, “Evidence that distinct neural pathways mediate parasympathetic contractions and relaxations of guinea-pig trachealis,” Journal of Physiology, vol. 471, pp. 25–40, 1993. View at Scopus
  38. A. E. McGovern and S. B. Mazzone, “Characterization of the vagal motor neurons projecting to the guinea pig airways and esophagus,” Frontiers in Neurology, vol. 1, article 153, 2010.
  39. M. Ichinose, H. Inoue, M. Miura, N. Yafuso, H. Nogami, and T. Takishima, “Possible sensory receptor of nonadrenergic inhibitory nervous system,” Journal of Applied Physiology, vol. 63, no. 3, pp. 923–929, 1987. View at Scopus
  40. N. J. Gross, E. Co, and M. S. Skorodin, “Cholinergic bronchomotor tone in COPD: estimates of its amount in comparison with that in normal subjects,” Chest, vol. 96, no. 5, pp. 984–987, 1989. View at Scopus
  41. D. W. Empey, L. A. Laitinen, and L. Jacobs, “Mechanisms of bronchial hyperreactivity in normal subjects after upper respiratory tract infection,” American Review of Respiratory Disease, vol. 113, no. 2, pp. 131–139, 1976. View at Scopus
  42. E. D. Bateman, O. Kornmann, P. Schmidt, A. Pivovarova, M. Engel, and L. M. Fabbri, “Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma,” Journal of Allergy and Clinical Immunology, vol. 128, no. 2, pp. 315–322, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. H. A. M. Kerstjens, B. Disse, W. Schröder-Babo et al., “Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial,” Journal of Allergy and Clinical Immunology, vol. 128, no. 2, pp. 308–314, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. R. Gosens, I. S. T. Bos, J. Zaagsma, and H. Meurs, “Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 10, pp. 1096–1102, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. J. Richardson and J. Beland, “Nonadrenergic inhibitory nervous system in human airways,” Journal of Applied Physiology, vol. 41, no. 5, pp. 764–771, 1976. View at Scopus
  46. G. Skloot, S. Permutt, and A. Togias, “Airway hyperresponsiveness in asthma: a problem of limited smooth muscle relaxation with inspiration,” Journal of Clinical Investigation, vol. 96, no. 5, pp. 2393–2403, 1995. View at Scopus
  47. C. Gratziou, N. Rovina, M. Lignos, et al., “Attenuation of deep inspiration (DI)—induced bronchoprotection (BP) by an NO synthase inhibitor,” American Journal of Respiratory and Critical Care Medicine, vol. 161, Article ID A830, 2001.
  48. F. L. M. Ricciardolo, P. Geppetti, A. Mistretta et al., “Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma,” The Lancet, vol. 348, no. 9024, pp. 374–377, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. G. T. De Sanctis, J. A. MacLean, K. Hamada et al., “Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma,” Journal of Experimental Medicine, vol. 189, no. 10, pp. 1621–1630, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. R. D. Dey, J. B. Altemus, A. Rodd, B. Mayer, S. I. Said, and R. F. Coburn, “Neurochemical characterization of intrinsic neurons in ferret tracheal plexus,” American Journal of Respiratory Cell and Molecular Biology, vol. 14, no. 3, pp. 207–216, 1996. View at Scopus
  51. A. Fischer and B. Hoffmann, “Nitric oxide synthase in neurons and nerve fibers of lower airways and in vagal sensory ganglia of man: correlation with neuropeptides,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 1, pp. 209–216, 1996. View at Scopus
  52. J. K. Ward, P. J. Barnes, D. R. Springall et al., “Distribution of human i-NANC bronchodilator and nitric oxide-immunoreactive nerves.,” American Journal of Respiratory Cell and Molecular Biology, vol. 13, no. 2, pp. 175–184, 1995. View at Scopus
  53. H. Maarsingh, J. Zaagsma, and H. Meurs, “Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives,” British Journal of Pharmacology, vol. 158, no. 3, pp. 652–664, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. H. Grasemann, C. N. Yandava, K. Storm Van's Gravesande et al., “A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma,” Biochemical and Biophysical Research Communications, vol. 272, no. 2, pp. 391–394, 2000. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Grasemann, C. N. Yandava, and J. M. Drazen, “Neuronal NO synthase (NOS1) is a major candidate gene for asthma,” Clinical and Experimental Allergy, Supplement, vol. 29, supplement 4, pp. 39–41, 1999. View at Scopus
  56. M. E. Wechsler, H. Grasemann, A. Deykin et al., “Exhaled nitric oxide in patients with asthma: association with NOS1 genotype,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 6, pp. 2043–2047, 2000. View at Scopus
  57. S. Ollerenshaw, D. Jarvis, A. Woolcock, C. Sullivan, and T. Scheibner, “Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma,” The New England Journal of Medicine, vol. 320, no. 19, pp. 1244–1248, 1989. View at Scopus
  58. J. Widdicombe, “Why are the airways so vascular?” Thorax, vol. 48, no. 3, pp. 290–295, 1993. View at Scopus
  59. J. W. Wilson and S. Hii, “The importance of the airway microvasculature in asthma,” Current Opinion in Allergy and Clinical Immunology, vol. 6, no. 1, pp. 51–55, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. M. E. Csete, A. D. Chediak, W. M. Abraham, and A. Wanner, “Airway blood flow modifies allergic airway smooth muscle contraction,” American Review of Respiratory Disease, vol. 144, no. 1, pp. 59–63, 1991. View at Scopus
  61. S. B. Mazzone, L. H. K. Lim, E. M. Wagner, N. Mori, and B. J. Canning, “Sympathetic nerve-dependent regulation of mucosal vascular tone modifies airway smooth muscle reactivity,” Journal of Applied Physiology, vol. 109, no. 5, pp. 1292–1300, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. E. M. Wagner and W. M. Foster, “Importance of airway blood flow on particle clearance from the lung,” Journal of Applied Physiology, vol. 81, no. 5, pp. 1878–1883, 1996. View at Scopus
  63. G. W. Chalmers, E. A. Millar, S. A. Little, M. C. Shepherd, and N. C. Thomson, “Effect of infused angiotensin II on the bronchoconstrictor activity of inhaled endothelin-1 in asthma,” Chest, vol. 115, no. 2, pp. 352–356, 1999. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Myou, M. Fujimura, K. Kurashima, H. Tachibana, K. Watanabe, and T. Hirose, “Type 1 angiotensin II receptor antagonism reduces antigen-induced airway reactions,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 1, pp. 45–49, 2000. View at Scopus
  65. D. R. Baldwin, Z. Sivardeen, I. D. Pavord, and A. J. Knox, “Comparison of the effects of salbutamol and adrenaline on airway smooth muscle contractility in vitro and on bronchial reactivity in vivo,” Thorax, vol. 49, no. 11, pp. 1103–1108, 1994. View at Scopus
  66. J. G. Widdicombe, “Neural control of airway vasculature and edema,” American Review of Respiratory Disease, vol. 143, no. 3, pp. S18–S21, 1991. View at Scopus
  67. K. Mullane, “Asthma translational medicine: report card,” Biochemical Pharmacology, vol. 82, no. 6, pp. 567–585, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. K. Mullane, “The increasing challenge of discovering asthma drugs,” Biochemical Pharmacology, vol. 82, no. 6, pp. 586–599, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. Z. Diamant, J. T. Hiltermann, E. L. Van Rensen et al., “The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 155, no. 4, pp. 1247–1253, 1997. View at Scopus
  70. H. Z. Shi, C. Q. Xiao, D. Zhong et al., “Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 1, pp. 204–209, 1998. View at Scopus
  71. W. J. Calhoun, B. J. Lavins, M. C. Minkwitz, R. Evans, G. J. Gleich, and J. Cohn, “Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental antigen challenge,” American Journal of Respiratory and Critical Care Medicine, vol. 157, no. 5, pp. 1381–1389, 1998. View at Scopus
  72. L. C. Borish, H. S. Nelson, M. J. Lanz et al., “Interleukin-4 receptor in moderate atopic asthma: a phase I/II randomized, placebo-controlled trial,” American Journal of Respiratory and Critical Care Medicine, vol. 160, no. 6, pp. 1816–1823, 1999. View at Scopus
  73. J. Corren, R. F. Lemanske, N. A. Hanania, et al., “Lebrikizumab treatment in adults with asthma,” The New England Journal of Medicine, vol. 365, no. 12, pp. 1088–1098, 2011.
  74. G. M. Gauvreau, L. P. Boulet, D. W. Cockcroft et al., “Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 8, pp. 1007–1014, 2011. View at Publisher · View at Google Scholar · View at Scopus